問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
田亞中
下載
2024-12-16 - 2029-12-31
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2024-12-30 - 2031-06-30
2016-03-15 - 2018-03-15
Renal Anemia
UB-851
Participate Sites18Sites
Recruiting10Sites
Terminated8Sites
Division of Nephrology
2019-06-15 - 2023-09-14
IgA Nephropathy
Cemdisiran (ALN-CC5)
Participate Sites6Sites
Recruiting6Sites
2018-01-01 - 2022-01-31
Moderate to Severe Chronic Kidney Disease (stage 3B to 4)
ELIXCYTE
Participate Sites3Sites
Recruiting3Sites
全部
